March 17, 2025 · Form 4 insider transaction
Culhane Mark bought 38,136 shares of GENASYS INC at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Represents restricted stock units (RSUs) that vest upon the earlier of (i) the date of the Company's 2026 annual shareholder meeting or (ii) a change of control event. Each RSU represents a contingent right to one share of the Company's common stock and is eligible to be settled solely in shares of the Company's common stock.